National Drug Control Policy Office 2007 – Federal Register Recent Federal Regulation Documents

Paperwork Reduction Act; Notice of Intent To Collect; Comment Request
Document Number: E7-24870
Type: Notice
Date: 2007-12-21
Agency: National Drug Control Policy Office, Executive Office of the President
This action proposes the collection of drug control information from federal, state, and local governments.
Leadership Conference on Medical Education in Substance Abuse
Document Number: E7-24024
Type: Notice
Date: 2007-12-12
Agency: National Drug Control Policy Office, Executive Office of the President
A conference of leaders in the field of medical education and healthcare policy will be held on Wednesday, January 16th, 2008 at the Hyatt Regency Hotel, Washington, DC on Capitol Hill, New Jersey Ave., NW., and Washington DC, starting at 8 a.m. and concluding at 5:30 p.m. The overall objectives of the Leadership Conference are to advance widespread use of screening and brief intervention procedures designed to identify and promote behavioral change in populations engaged in risky, problematic substance use, or that have a diagnosis of abuse/ addiction. Abuse of illicit drugs, alcohol, or prescription drugs adversely affects the health of millions of Americans. Wide-spread implementation of screening and brief intervention procedures can have a major, positive impact on public health. The specific conference objectives are: (1) To share with medical educators and other contributors to improving in public health, the positive benefits of screening and brief interventions; (2) To devise strategies to implement and sustain Screening, Brief Intervention and Referral to Treatment (SBIRT) procedures for substance abuse in various healthcare settings; (3) To promote adoption and use of new reimbursable healthcare procedural codes (screening and brief intervention) and examine cost-effectiveness of implementing the codes; (4) To address best practices for performing these procedures in various healthcare settings; (5) To identify challenges to implementation of these procedures in various healthcare settings and conceptualize strategies to address these challenges; (6) To generate business models for the procedures applicable to specific heath care environments; (7) To address training and educational needs for the medical community and devise efficient methods for widespread dissemination of these practices. Members of the public who wish to attend the meeting should telephone ONDCP's Leadership Conference on Medical Education telephone line at (202) 395-6750 to arrange building access.
High Intensity Drug Trafficking Areas; Petitions for Designation
Document Number: E7-16174
Type: Notice
Date: 2007-08-16
Agency: Executive Office of the President, National Drug Control Policy Office
Pursuant to the Office of National Drug Control Policy Reauthorization Act of 2006, Public Law 109-469, section 707(c), the Director, National Drug Control Policy is establishing regulations under which interested coalitions of law enforcement agencies from an area may petition for designation as a high intensity drug trafficking area. Public Comment: On June 4, 2007 (Volume 72, Number 106, Notices Page 30862-30864), the Executive Office of the President, Office of National Drug Control published Notice of its intent to issue this regulation. A 60-day public comment period was established. The June 4 Notice stated that any written comments must be received by ONDCP via electronic mail or facsimile on or before August 3, 2007. In addition, an ONDCP staff point of contact was listed to provide additional information as appropriate. ONDCP did not receive any comments. Therefore, ONDCP is issuing this Notice of the agency's intent to publish a regulation identical to the document published on June 4, 2007.
High Intensity Drug Trafficking Areas; Petitions for Designation
Document Number: E7-10640
Type: Notice
Date: 2007-06-04
Agency: Executive Office of the President, National Drug Control Policy Office
Pursuant to the Office of National Drug Control Policy Reauthorization Act of 2006, Public Law 109-469, section 707(c), the Director, National Drug Control Policy is establishing regulations under which interested coalitions of law enforcement agencies from an area may petition for designation as a high intensity drug trafficking area.
Meeting of the Advisory Commission on Drug Free Communities
Document Number: E7-10390
Type: Notice
Date: 2007-05-31
Agency: National Drug Control Policy Office, Executive Office of the President
In accordance with the Drug-Free Communities Act, a meeting of the Advisory Commission on Drug Free Communities will be held on June 27 and 28, 2007 at the Office of National Drug Control Policy in the 5th Floor Conference Room, 750 17th Street, NW., Washington, DC. The meeting will commence at 8:30 a.m. on Wednesday, June 27th, 2007 and adjourn for the evening at 5 p.m. The meeting will reconvene at 8:30 a.m. on Thursday, June 28th, 2007 in the same location. The meeting will adjourn at 4 p.m. on Thursday, June 28th, 2007. The agenda is slated to include: Remarks by ONDCP Director John P. Walters, remarks by the DFC Program's Administrator, Jack Claypoole, and remarks by Policy Analyst Ken Shapiro. There will also be a discussion of the program's evaluation, a discussion about the reauthorization of the Drug Free Communities Program, a review of the new grant process, and an update from the Substance Abuse and Mental Health Services Administration. There will be an opportunity for public comment from 9- 9:30 on Thursday, June 28th, 2007. Members of the public who wish to attend the meeting and/or make public comment should contact ShaNice Stokes, at (202) 395-6699 to arrange building access.
Paperwork Reduction Act; 30-Day Notice; Correction
Document Number: E7-765
Type: Notice
Date: 2007-01-22
Agency: National Drug Control Policy Office, Executive Office of the President
Paperwork Reduction Act; 30-Day Notice
Document Number: E7-342
Type: Notice
Date: 2007-01-12
Agency: National Drug Control Policy Office, Executive Office of the President